Biomarker development for Huntington's disease.

@article{Andr2014BiomarkerDF,
  title={Biomarker development for Huntington's disease.},
  author={Ralph Andr{\'e} and Rachael I. Scahill and Salman Haider and Sarah J Tabrizi},
  journal={Drug discovery today},
  year={2014},
  volume={19 7},
  pages={972-9}
}
Huntington's disease (HD) is a fatal inherited neurodegenerative disorder, treatment to slow the progression of which has not yet been found. Human clinical trials to test a number of therapeutic strategies are underway or imminent, facilitated in part by the recent development of biomarkers that might be used as surrogate endpoints in such trials. However, although much progress in developing HD biomarkers has been made, ongoing work seeks to improve the sensitivity and reliability of current… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…